Clinical Trials Browser

Phase 1 × Melanoma × ADI PEG20 × Clear all

NCT01665183 2016-02-25

Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma

Phase 1 Completed

DermatologicGynecologic

Uveal Melanoma, Melanoma, Ovarian Neoplasms

NCT00029900 2015-03-25

ADI-PEG in Patients With Metastatic Melanoma

Phase 1 Completed

Melanoma, Neoplasm Metastasis